These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 23689062)
21. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. Zhou J; Sun XY; Louis K; Frazer IH J Virol; 1994 Feb; 68(2):619-25. PubMed ID: 8289365 [TBL] [Abstract][Full Text] [Related]
22. Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection. Day PM; Weisberg AS; Thompson CD; Hughes MM; Pang YY; Lowy DR; Schiller JT J Virol; 2019 Aug; 93(15):. PubMed ID: 31092566 [TBL] [Abstract][Full Text] [Related]
23. Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16. El Mehdaoui S; Touzé A; Laurent S; Sizaret PY; Rasschaert D; Coursaget P J Virol; 2000 Nov; 74(22):10332-40. PubMed ID: 11044077 [TBL] [Abstract][Full Text] [Related]
24. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens. Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304 [No Abstract] [Full Text] [Related]
25. Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism. Day PM; Thompson CD; Lowy DR; Schiller JT J Virol; 2017 May; 91(10):. PubMed ID: 28250129 [TBL] [Abstract][Full Text] [Related]
26. Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection. Popa A; Zhang W; Harrison MS; Goodner K; Kazakov T; Goodwin EC; Lipovsky A; Burd CG; DiMaio D PLoS Pathog; 2015 Feb; 11(2):e1004699. PubMed ID: 25693203 [TBL] [Abstract][Full Text] [Related]
27. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749 [TBL] [Abstract][Full Text] [Related]
28. An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins. Windram OP; Weber B; Jaffer MA; Rybicki EP; Shepherd DN; Varsani A Arch Virol; 2008; 153(3):585-9. PubMed ID: 18175039 [TBL] [Abstract][Full Text] [Related]
29. Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry. DiGiuseppe S; Keiffer TR; Bienkowska-Haba M; Luszczek W; Guion LG; Müller M; Sapp M J Virol; 2015 Oct; 89(20):10442-52. PubMed ID: 26246568 [TBL] [Abstract][Full Text] [Related]
30. Modification of human papillomavirus minor capsid protein L2 by sumoylation. Marusic MB; Mencin N; Licen M; Banks L; Grm HS J Virol; 2010 Nov; 84(21):11585-9. PubMed ID: 20739540 [TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm. Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736 [TBL] [Abstract][Full Text] [Related]
32. The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network. DiGiuseppe S; Bienkowska-Haba M; Hilbig L; Sapp M Virology; 2014 Jun; 458-459():93-105. PubMed ID: 24928042 [TBL] [Abstract][Full Text] [Related]
33. The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation. Siddiqa A; Léon KC; James CD; Bhatti MF; Roberts S; Parish JL J Gen Virol; 2015 Aug; 96(8):2274-2285. PubMed ID: 25911730 [TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles. Heino P; Dillner J; Schwartz S Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535 [TBL] [Abstract][Full Text] [Related]
35. Target cell cyclophilins facilitate human papillomavirus type 16 infection. Bienkowska-Haba M; Patel HD; Sapp M PLoS Pathog; 2009 Jul; 5(7):e1000524. PubMed ID: 19629175 [TBL] [Abstract][Full Text] [Related]
36. Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection. Yang R; Yutzy WH; Viscidi RP; Roden RB J Biol Chem; 2003 Apr; 278(14):12546-53. PubMed ID: 12560332 [TBL] [Abstract][Full Text] [Related]
37. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908 [TBL] [Abstract][Full Text] [Related]
38. Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection. Cruz L; Biryukov J; Conway MJ; Meyers C Viruses; 2015 Nov; 7(11):5813-30. PubMed ID: 26569287 [TBL] [Abstract][Full Text] [Related]
39. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16. Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361 [TBL] [Abstract][Full Text] [Related]
40. Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. Day PM; Thompson CD; Schowalter RM; Lowy DR; Schiller JT J Virol; 2013 Apr; 87(7):3862-70. PubMed ID: 23345514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]